author-photo

Kerry L. Cox

University of Southampton

32

Papers

968

Citations

Citation Trend

Filter By

Papers (26) Sort By

Journal Conference Others

FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion.

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (1)
BET inhibitors synergize with venetoclax to induce apoptosis in MYC-driven lymphomas with high BCL-2 expression

2020 Blood Advances
Show All
- Source
- Cite
- Save
Citations (9)
Domain binding and isotype dictate the activity of anti-human OX40 antibodies.

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (3)
HIGH EXPRESSION OF BCL-2 AND BCL-XL IN DIFFUSE LARGE B-CELL LYMPHOMA CONFER POOR PROGNOSIS BUT MAY BE REVERSIBLE BY COMBINED INHIBITION WITH BET INHIBITORS AND BH3 MIMETICS.

2019 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The PI3Kδ-Selective Inhibitor Idelalisib Minimally Interferes with Immune Effector Function Mediated by Rituximab or Obinutuzumab and Significantly Augments B Cell Depletion In Vivo

2018 Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (9)
Lamin B1 regulates somatic mutations and progression of B-cell malignancies

2018 Leukemia
Show All
- Source
- Cite
- Save
Citations (11)
STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (43)
Antibody Tumor Targeting Is Enhanced by CD27 Agonists through Myeloid Recruitment

2017 Cancer Cell
Show All
- Source
- Cite
- Save
Citations (31)
CD27 STIMULATION ENHANCES CD20 MAB THERAPY THROUGH ACTIVATION OF INNATE IMMUNITY

2017 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures

2017 Molecular & Cellular Proteomics
Show All
- Source
- Cite
- Save
Citations (13)